Position in CHRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,339
-$2,380 QoQ
Shares Held
18,814
+10.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 147 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. CHRS ranks #107 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
|
50,301 | $5,702,121 |
All Filings in CHRS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,339 | 18,814 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $28,719 | 16,994 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,621 | 13,114 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,649 | 10,762 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $8,824 | 12,072 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $9,012 | 11,168 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,849 | 11,485 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,540 | 18,789 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,715 | 11,396 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $25,111 | 10,507 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $159,350 | 42,607 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $101,391 | 23,745 | Shares | Sole | 2023-08-15 | |
| 2022-06-30 | $19,729 | 2,725 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $31,035 | 2,404 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,457 | 154 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,008 | 125 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $8,823 | 638 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,258 | 223 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,172 | 125 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $35,720 | 2,000 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||